A study found an increase in white matter lesions and decrease in grey matter volume in metastatic NSCLC patients following long-term EGFR-TKI treatment, which indicated that structural and functional changes in the brain are strongly correlated with the cognitive status of patients [16]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.